Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06792292 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Artificial Intelligence-Assisted Colonoscopy in Colorectal Cancer Screening in a General Hospital

Study acronym: Delta-AI
StatusNot Yet Recruiting
PhaseNot applicable
SponsorChirec
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
3 trials monitored
See all monitored trials
3,394 trials monitored
See 159 trials at risk
Cancer can develop in the colon, or large bowel. Examination of the colon with a tube fitted with a camera is called a colonoscopy. Colonoscopy allows detection of small growths in the colon, called "polyps". Polyps can often be removed during colonoscopy. Some of these polyps are called adenomas and can become cancer after several years. A good colonoscopy aims to find and take out as many of these polyps as possible. A quality indication of colonoscopy is the "adenoma detection rate" (ADR). It should be high, meaning many polyps are detected and taken out. New artificial intelligence devices to assist colonoscopy seem to increase the ADR, and maybe help prevent cancer even better than normal colonoscopy. The goal of this clinical trial is to compare the ADR when using standard colonoscopy to the ADR with artificial intelligence (AI)-assisted colonoscopy.
Trial Details
NCT Number NCT06792292
Lead Sponsor Chirec
Conditions
(from sponsor)
Artificial Intelligence, Colonic Adenoma, Colonic Neoplasms, Colonic Polyp, Colonoscopy
Related terms Colonic Neoplasms, Colonic Polyps
Enrollment 765 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov